Herpès chronique périnéal résistant à l’aciclovir révélateur d’une leucémie lymphoïde chronique

Gbery, 1999, Chronic genital ulcerations and HIV infection: 29 cases, Med Trop, 59, 279 Landolsi, 2003, Perianal ulceration revealing langherans cell histiocytosis, Tunis Med, 81, 967 Lévy, 2006, Buschke-Lowenstein tumour: diagnosis and treatment, Ann Urol, 40, 175, 10.1016/j.anuro.2006.02.002 Cheshire, 2009, Acquired acrodermatitis enteropathica due to zinc deficiency in a patient with pre-existing Darier's disease, J Dermatol Case Rep, 3, 41, 10.3315/jdcr.2009.1032 Trotti, 2003, CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment, Semin Radiat Oncol, 13, 176, 10.1016/S1053-4296(03)00031-6 Agence nationale d’accréditation et d’évaluation en santé, 2002, Management of cutaneo-mucosal herpes in immunocompetent patients (ocular manifestations excluded), Presse Med, 31, 363 Piret, 2011, Minireview, resistance of herpes simplex virus to nucleoside analogues: mechanisms, prevalence and management, Antimicrob Agents Chemother, 55, 459, 10.1128/AAC.00615-10 Bacon, 2003, Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy, Clin Microbiol Rev, 16, 114, 10.1128/CMR.16.1.114-128.2003 Beutner, 1995, Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy, Antiviral Res, 28, 281, 10.1016/0166-3542(95)00066-6 Soul-Lawton, 1995, Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans, Antimicrob Agents Chemother, 39, 2759, 10.1128/AAC.39.12.2759 Danve-Szatanek, 2004, Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up, J Clin Microbiol, 42, 242, 10.1128/JCM.42.1.242-249.2004 Dearden, 2008, Disease-specific complications of chronic lymphocytic leukemia, Hematology Am Soc Hematol Educ Program, 450, 10.1182/asheducation-2008.1.450 Field, 1989, Persistent herpes simplex virus infection and mechanisms of virus drug resistance, Eur J Clin Microbiol Infect Dis, 8, 671, 10.1007/BF01963751 Field, 1982, Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy, Antimicrob Agents Chemother, 21, 744, 10.1128/AAC.21.5.744 Christophers, 1998, Survey of resistance of herpes simplex virus to acyclovir in Northwest England, Antimicrob Agents Chemother, 42, 868, 10.1128/AAC.42.4.868 Burrel, 2010, Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals, Antimicrob Agents Chemother, 54, 4833, 10.1128/AAC.00669-10 Burrel, 2012, Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity, Antiviral Res, 96, 386, 10.1016/j.antiviral.2012.09.016 Swetter, 1998, Chronic vulvar ulceration in an immunocompetent woman due to acyclovir resistant, thymidine kinase deficient herpes simplex virus, J Infect Dis, 177, 543, 10.1086/514229 Gilquin, 1990, Genital and oral erosions induced by foscarnet, Lancet, 335, 287, 10.1016/0140-6736(90)90101-A Perkins, 2011, Topical imiquimod treatement of aciclovir – resistant herpes simplex disease: case series and literature review, Sex Transm Infect, 87, 292, 10.1136/sti.2010.047431 Gilbert, 2001, Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection, Arch Dermatol, 137, 1015 Sbidian, 2013, Recalcitrant pseudotumoral anogenitalherpes simplex virus type 2 in HIV-infected patients: effective therapeutic strategy, Clin Infect Dis, 57, 1648, 10.1093/cid/cit592 Coen, 1989, Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate, Proc Natl Acad Sci USA, 86, 4736, 10.1073/pnas.86.12.4736 Holmes, 2007, Thalidomide therapy for the treatment of hypertrophic herpes simplex virus-related genitalis in HIV-infected individuals, Clin Infect Dis, 44, 96, 10.1086/517513 Efstathiou, 1989, The role of herpes simplex virus type 1 thymidine kinase in pathogenesis, J Gen Virol, 70, 869, 10.1099/0022-1317-70-4-869 Jacobson, 1993, Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia, J Virol, 67, 6903, 10.1128/JVI.67.11.6903-6908.1993 Tenser, 1987, Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation, J Virol, 61, 2171, 10.1128/JVI.61.7.2171-2174.1987 Van Velzen, 2012, Latent acyclovir – resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals, J Infect Dis, 205, 1539, 10.1093/infdis/jis237